2019 Onchocerciasis (River Blindness) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

April 2019 | 47 pages | ID: 257DB02E213EN
VPAResearch

Abstracts

The global clinical trial report- “2019 Onchocerciasis (River Blindness) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Onchocerciasis (River Blindness). It presents in-depth analysis of Onchocerciasis (River Blindness) clinical trials across markets and companies. The research work is for providing complete understanding into trends in Onchocerciasis (River Blindness).

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Onchocerciasis (River Blindness) clinical trials by-

• Current Trial Status
• Type of the trial
• Sponsor Type
• Enrollment Trends
• Region
• Countries
• Trial Phase

The report also identifies the potential drug candidates under development for treatment of Onchocerciasis (River Blindness)

The research work is prepared through extensive and continuous research on Onchocerciasis (River Blindness) trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:

• All major trials from 2010 to 2019 and planned trials are included in the report scope.
• Drug candidates currently being researched for administering Onchocerciasis (River Blindness) patients are identified
• The report includes panorama of Onchocerciasis (River Blindness) clinical trials across the globe
• Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
• Companies and universities focusing on Onchocerciasis (River Blindness) clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
• Average Enrollment number, insights into enrollment trends, company wise enrollment are included
• Both interventional and observational studies are analyzed
• News and latest developments for the past one year are presented in the report

Contents

1. TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2. EXECUTIVE SUMMARY

2.1 Onchocerciasis (River Blindness) Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
  2.2.1 Onchocerciasis (River Blindness) Clinical Trials by Region
  2.2.2 Average Enrollment of Onchocerciasis (River Blindness) Clinical Trials
  2.2.3 Companies participating in Trials
  2.2.4 Drugs under Study for Onchocerciasis (River Blindness) Treatment, 2019

3. REGION WISE ONCHOCERCIASIS (RIVER BLINDNESS) CLINICAL TRIALS

3.1 Asia Pacific Onchocerciasis (River Blindness) Clinical Trials by Country
3.2 Europe Onchocerciasis (River Blindness) Clinical Trials by Country
3.3 North America Onchocerciasis (River Blindness) Clinical Trials by Country
3.4 Middle East and Africa Onchocerciasis (River Blindness) Clinical Trials by Country
3.5 South and Central America Onchocerciasis (River Blindness) Clinical Trials by Country

4. ONCHOCERCIASIS (RIVER BLINDNESS) CLINICAL TRIAL TRENDS

4.1 Start Year wise Onchocerciasis (River Blindness) Clinical Trials
4.2 Phase wise Onchocerciasis (River Blindness) Clinical Trials
4.3 Trial Status wise Onchocerciasis (River Blindness) Clinical Trials
4.4 Trial Type wise Onchocerciasis (River Blindness) Clinical Trials

5. ONCHOCERCIASIS (RIVER BLINDNESS) AVERAGE ENROLLMENT TRENDS

5.1 Average Enrollment in Onchocerciasis (River Blindness) Trials by Year
5.2 Average Enrollment in Onchocerciasis (River Blindness) Trials by Phase
5.3 Average Enrollment in Onchocerciasis (River Blindness) Trials by Status
5.4 Average Enrollment in Onchocerciasis (River Blindness) Trials by Type of Trial

6. COMPANIES PARTICIPATING IN ONCHOCERCIASIS (RIVER BLINDNESS) CLINICAL TRIALS

6.1 Onchocerciasis (River Blindness) Trials by Sponsor Type
6.2 Onchocerciasis (River Blindness) Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS

7.1 Onchocerciasis (River Blindness) Trials- Phase
7.2 Onchocerciasis (River Blindness) Trials- Phase
7.3 Onchocerciasis (River Blindness) Trials- Phase
7.4 Onchocerciasis (River Blindness) Trials- Phase

8. APPENDIX

8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List Of Figures

LIST OF FIGURES

Figure 1: Onchocerciasis (River Blindness) Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Onchocerciasis (River Blindness) Clinical Trials and Enrolment
Figure 5: Europe – Country wise Onchocerciasis (River Blindness) Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Onchocerciasis (River Blindness) Clinical Trials and Enrolment
Figure 7: North America – Country wise Onchocerciasis (River Blindness) Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Onchocerciasis (River Blindness) Clinical Trials and Enrolment
Figure 9: Onchocerciasis (River Blindness) Clinical Trials by Phase
Figure 10: Onchocerciasis (River Blindness) Clinical Trials by Trial Status
Figure 11: Onchocerciasis (River Blindness) Clinical Trials by Type
Figure 12: Onchocerciasis (River Blindness) Clinical Trials by Sponsor Type
Figure 13: Onchocerciasis (River Blindness) Clinical Trials by Leading Sponsors
Figure 14: Onchocerciasis (River Blindness) Average Enrollment by Phase
Figure 15: Onchocerciasis (River Blindness) Average Enrollment by Trial Status
Figure 16: Onchocerciasis (River Blindness) Average Enrollment by Type
Figure 17: Onchocerciasis (River Blindness)- Average Enrolment by Type of Sponsors
Figure 18: Onchocerciasis (River Blindness)- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List Of Tables

LIST OF TABLES

Table 1: Onchocerciasis (River Blindness) Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Onchocerciasis (River Blindness) Clinical Trials and Enrolment
Table 5: Europe – Country wise Onchocerciasis (River Blindness) Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Onchocerciasis (River Blindness) Clinical Trials and Enrolment
Table 7: North America – Country wise Onchocerciasis (River Blindness) Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Onchocerciasis (River Blindness) Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Onchocerciasis (River Blindness) Average Enrollment by Phase
Table 15: Onchocerciasis (River Blindness) Average Enrollment by Trial Status
Table 16: Onchocerciasis (River Blindness) Average Enrollment by Type
Table 17: Onchocerciasis (River Blindness)- Average Enrolment by Type of Sponsors
Table 18: Onchocerciasis (River Blindness)- Enrolment by Leading Sponsors